SCHEMBL486204

SCHEMBL486204

CC1C(C(=O)Nc2ccccc2)CCCN1C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.49
▸ GAA P10253 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ FNTA P49354 1/20 0.46
▸ FNTB P49356 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HTT P42858 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ DPP4 P27487 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12160901 0.86 MEN1 (0.50) MAPTGAAALDH1A1CYP2C9CYP2C19
SCHEMBL12160727 0.86 MEN1 (0.50) MAPTGAAALDH1A1CYP2C9CYP2C19
SCHEMBL10337750 0.75 MAPT (0.78) MAPTGAAALDH1A1CYP2C19SMN1; SMN2
SCHEMBL105931 0.75 MAPT (0.78) MAPTGAAALDH1A1CYP2C19SMN1; SMN2
SCHEMBL4613765 0.73 RIPK1 (0.48) POLBL3MBTL1
SCHEMBL28486832 0.73 ALDH1A1 (0.59) ALDH1A1CYP2C9CYP2C19NPC1HTT
Hydrochloric Acid SCHEMBL28482321 0.72 ALDH1A1 (0.58) ALDH1A1CYP2C9CYP2C19NPC1HTT
SCHEMBL24725073 0.72 MAPT (0.50) MAPTGAAALDH1A1CYP2C9CYP2C19
SCHEMBL12160730 0.72 L3MBTL1 (0.47) MAPTGAAALDH1A1CYP2C9CYP2C19
SCHEMBL12160900 0.72 L3MBTL1 (0.47) MAPTGAAALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411363-A1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS Bayer Pharma AG (DE) 2012-02-01 — — EP disclosed
Send feedback